The global Drugs for Duchenne Muscular Dystrophy (DMD) market size was estimated at USD 198 million in 2024 and is projected to reach USD 514.76 million by 2032, exhibiting a CAGR of 11.20% during the forecast period.
North America Drugs for Duchenne Muscular Dystrophy (DMD) market size was estimated at USD 61.97 million in 2024, at a CAGR of 9.60% during the forecast period of 2025...
English
Arabic
French
Spanish
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek